↓ Skip to main content

Effects of Donepezil,Galantamine and Rivastigmine in 938 Italian Patients with Alzheimer’s Disease

Overview of attention for article published in CNS Drugs, August 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

news
1 news outlet

Readers on

mendeley
114 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effects of Donepezil,Galantamine and Rivastigmine in 938 Italian Patients with Alzheimer’s Disease
Published in
CNS Drugs, August 2012
DOI 10.2165/11310960-000000000-00000
Pubmed ID
Authors

Aurelia Santoro, Paola Siviero, Nadia Minicuci, Elena Bellavista, Michele Mishto, Fabiola Olivieri, Francesca Marchegiani, Andrea Maria Chiamenti, Luisa Benussi, Roberta Ghidoni, Benedetta Nacmias, Silvia Bagnoli, Andrea Ginestroni, Osvaldo Scarpino, Emidio Feraco, Walter Gianni, Guido Cruciani, Roberto Paganelli, Angelo Di Iorio, Mario Scognamiglio, Luigi Maria Edoardo Grimaldi, Carlo Gabelli, Sandro Sorbi, Giuliano Binetti, Gaetano Crepaldi, Claudio Franceschi

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Japan 1 <1%
United States 1 <1%
Brazil 1 <1%
Unknown 110 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 17%
Student > Ph. D. Student 14 12%
Student > Master 13 11%
Other 9 8%
Student > Postgraduate 8 7%
Other 28 25%
Unknown 23 20%
Readers by discipline Count As %
Medicine and Dentistry 23 20%
Psychology 17 15%
Neuroscience 9 8%
Nursing and Health Professions 6 5%
Agricultural and Biological Sciences 6 5%
Other 24 21%
Unknown 29 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2019.
All research outputs
#4,836,164
of 25,374,647 outputs
Outputs from CNS Drugs
#440
of 1,388 outputs
Outputs of similar age
#34,105
of 187,955 outputs
Outputs of similar age from CNS Drugs
#143
of 541 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,388 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.6. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,955 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 541 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.